top of page
Clinical Cancer Research.png
nature cell biology volume 25 - Jan 2023.png
Cancer Cell VOlume 40 Issue 10.gif
Cancer Cell volume 36 Issue 4.gif
Nature Reviews Molucular Cell Bio Vol 20 Issue 10.png
Nature Volume 549 Issue 7670.png

Molecular and Pathologic Characterization of YAP1-Expressing Small Cell Lung Cancer Cell Lines Leads to Reclassification as SMARCA4-Deficient Malignancies. Clinical Cancer Research. 2024  May 1;30(9):1846-1858. doi: 10.1158/1078-0432.CCR-23-2360


Targeting Menin disrupts the KMT2A/B and polycomb balance to paradoxically activate bivalent genes. Nature Cell Biology. 2023 Feb; 25(2):258-272. doi: 10.1038/s41556-022-01056-x


Inhibition of the CtBP complex and FBXO11 enhances MHC class II expression and anti-cancer immune responses ​Cancer Cell. 2022 Oct 10;40(10):1190-1206.e9. doi: 10.1016/j.ccell.2022.09.007. Epub 2022 Sep 29.


An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer. Cancer Cell. 2019 Oct 14;36(4):385-401 doi: 10.1016/j.ccell.2019.08.008



The roles of DNA, RNA and histone methylation in ageing and cancer, Nature Reviews Molecular Cell Biology. 2019. Oct 20(10):573-589. doi: 10.1038/s41580-019-0143-1



CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity. Nature. 2017 Sep 7;549 (7670): 101-105 doi: 10.1038/nature23643

bottom of page